BREAKING NEWS: FDA Approves Darolutamide for Metastatic Hormone-Sensitive Prostate Cancer (read more here).
Go here to learn more or to get a mailed copy.
Home » Bio » Board Members » Keith B. Shoates
View All Board Members here.
Vice President, Office of the CEOVista Equity Partners
